Aloïs Gratwohl
About
In The Last Decade
Aloïs Gratwohl
509 papers receiving 23.1k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Hematology 17.1k
- Immunology 5.7k
- Genetics 4.8k
- Oncology 4.7k
- Public Health, Environmental and Occupational Health 4.4k
Countries citing papers authored by Aloïs Gratwohl
This map shows the geographic impact of Aloïs Gratwohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aloïs Gratwohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aloïs Gratwohl more than expected).
Fields of papers citing papers by Aloïs Gratwohl
This network shows the impact of papers produced by Aloïs Gratwohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aloïs Gratwohl. The network helps show where Aloïs Gratwohl may publish in the future.
Co-authorship network of co-authors of Aloïs Gratwohl
This figure shows the co-authorship network connecting the top 25 collaborators of Aloïs Gratwohl. A scholar is included among the top collaborators of Aloïs Gratwohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aloïs Gratwohl. Aloïs Gratwohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 10 | |
| 3 | 27 | |
| 4 | 155 | |
| 5 | 345 | |
| 6 | 134 | |
| 7 | 97 | |
| 8 | 181 | |
| 9 | Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey. | 15 |
| 10 | The EBMT Activity Survey on Hematopoietic Stem Cell Transplantation: A novel Instrument for Quality Control | 1 |
| 11 | Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT. | 1 |
| 12 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 1 |
| 13 | Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: An analysis of the chronic leukaemia working party of the European blood and marrow transplantation group (EBMT) | 4 |
| 14 | FAHCT-JACIE workshop on accreditation for blood and marrow progenitor cell processing, collection and transplantation Barcelona, Spain January 22-23, 2000 | 2 |
| 15 | 66 | |
| 16 | 79 | |
| 17 | Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT). | 37 |
| 18 | EBMT survey on bone marrow transplant activity in Europe: regional differences. | 1 |
| 19 | Bone marrow transplants using volunteer donors - Recommendations and requirements for a standardized practice throughout the world | 19 |
| 20 | Allogeneic bone marrow transplantation for leukaemia in Europe | 65 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.